Biotech Meabco expands collaboration with US government
New study results for Meabco's treatment against radiation damage has generated so much attention from collaborative partners in the US government that the latter now intends to expand the deal with the Danish biotech company.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.